TSH Biopharm working together with InnoPharmax and Shandong Newtime Pharmacutical enter into global agreement ofGlobal Agreement • January 5th, 2021
Contract Type FiledJanuary 5th, 2021TSH Biopharm (8432) and InnoPharmax today(7/8) announced granting Shandong Newtime Pharmaceutical an exclusive rights to commercialize pipeline product CRTA04, a treating chronic heart failure of ischemic agent in worldwide.